Merz Aesthetics announced that the FDA has approved incobotulinum toxin A (Xeomin) for the temporary improvement in the appearance of frown lines. This product was approved by the FDA in July of 2010 for the treatment of cervical dystonia and blepharospasm, but has recently been approved for cosmetic use in the U.S.A. This product has been used in 14 other counties under the brand name Bocouture for the treatment of frown lines.
With this recent FDA approval, you will be hearing more about Xeomin in the news and media. In the near future, we will see how it compares to Botox and Dysport in respect to:
- the time it takes to see improvement
- how long it lasts